Gynecomastia

Endocrinology: Adult and Pediatric, Sixth Edition

Volumn 2, Issue , 2010, Pages 2544-2555

  Santen, Richard J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895797712     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5583-9.00140-4     Document Type: Chapter

References (189)

1. J Russo, RJ Santen and IH Russo (2006) Hormonal control of breast development. LJ DeGroot, JL Jameson,(Eds) Endocrinology ed 5 Philadelphia: Saunders 3045-3055.
2. RW Casey and JD Wilson (1984) Antiestrogenic action of dihydrotestosterone in mouse breast. Competition with estradiol for binding to the estrogen receptor. J Clin Invest 74 2272-2278.
3. HS Narula and HE Carlson (2007) Gynecomastia. Endocrinol Metab Clin North Am 36 497-519.
4. M Nydick, J Bustos, JH Dale Jr, et al. (1961) Gynecomastia in adolescent boys. JAMA 178 449-454.
5. FM Biro, AW Lucky, GA Huster, et al. (1990) Hormonal studies and physical maturation in adolescent gynecomastia. J Pediatr 116 450-455.
6. PA Lee (1975) The relationship of concentrations of serum hormones to pubertal gynecomastia. J Pediatr 86 212-215.
7. SH LaFranchi, AF Parlow, BM Lippe, et al. (1975) Pubertal gynecomastia and transient elevation of serum estradiol level. Am J Dis Child 129 927-931.
8. D Knorr and F Bidlingmaier (1975) Gynaecomastia in male adolescents. Clin Endocrinol Metab 4 157-171.
9. DM Large and DC Anderson (1979) Twenty-four hour profiles of circulating androgens and oestrogens in male puberty with and without gynaecomastia. Clin Endocrinol (Oxf) 11 505-521.
10. DC Moore, LV Schlaepfer, L Paunier, et al. (1984) Hormonal changes during puberty: V: Transient pubertal gynecomastia: abnormal androgen-estrogen ratios. J Clin Endocrinol Metab 58 492-499.
11. FQ Nuttall (1979) Gynecomastia as a physical finding in normal men. J Clin Endocrinol Metab 48 338-340.
12. HE Carlson (1980) Gynecomastia. N Engl J Med 303 795-799.
13. SB Ley (1980) Palpable breast tissue versus gynecomastia as a normal physical finding. Clin Res 28 24A. [abstract] Mozaffarian GA LJ, editor
14. CB Niewoehner and FQ Nuttal (1984) Gynecomastia in a hospitalized male population. Am J Med 77 633-638.
15. E Georgiadis, L Papandreou, C Evangelopoulou, et al. (1994) Incidence of gynaecomastia in 954 young males and its relationship to somatometric parameters. Ann Hum Biol 21 579-587.
16. JA Andersen and JB Gram (1982) Male breast at autopsy. Acta Pathol Microbiol Immunol Scand A 90 191-197.
17. MJ Williams (1963) Gynecomastia. Its incidence, recognition and host characterization in 447 autopsy cases. Am J Med 34 103-112.
18. GA Bannayan and SI Hajdu (1972) Gynecomastia: clinicopathologic study of 351 cases. Am J Clin Pathol 57 431-437.
19. GL Nicolis, RS Modlinger and JL Gabrilove (1971) A study of the histopathology of human gynecomastia. J Clin Endocrinol Metab 32 173-178.
20. J Cavanaugh, CB Niewoehner and FQ Nuttall (1990) Gynecomastia and cirrhosis of the liver. Arch Intern Med 150 563-565.
21. U Mandava, N Kirma and RR Tekmal (2001) Aromatase overexpression transgenic mice model: cell type specific expression and use of letrozole to abrogate mammary hyperplasia without affecting normal physiology. J Steroid Biochem Mol Biol 79 27-34.
22. X Li, A Warri, S Makela, et al. (2002) Mammary gland development in transgenic male mice expressing human P450 aromatase. Endocrinology 143 4074-4083.
23. GD Braunstein (2007) Clinical practice. Gynecomastia. N Engl J Med 357 1229-1237.
24. AT Sandison (1962) An autopsy study of the adult human breast: with special reference to proliferative epithelial changes of importance in the pathology of the breast. J Natl Cancer Inst Monogr 4 1-145.
25. DD Dershaw (1986) Male mammography. Am J Roentgenol 146 127-131.
26. TJ Rissanen, HP Makarainen, MJ Kallioinen, et al. (1992) Radiography of the male breast in gynecomastia. Acta Radiol 33 110-114.
27. AH Appelbaum, GF Evans, KR Levy, et al. (1999) Mammographic appearances of male breast disease. Radiographics 19 559-568.
28. VP Jackson and RL Gilmor (1983) Male breast carcinoma and gynecomastia: comparison of mammography with sonography. Radiology 149 533-536.
29. I Gunhan-Bilgen, H Bozkaya, EE Ustun, et al. (2002) Male breast disease: clinical, mammographic, and ultrasonographic features. Eur J Radiol 43 246-255.
30. SP Weinstein, EF Conant, SG Orel, et al. (2000) Spectrum of US findings in pediatric and adolescent patients with palpable breast masses. Radiographics 20 1613-1621.
31. GF Evans, T Anthony, RH Turnage, et al. (2001) The diagnostic accuracy of mammography in the evaluation of male breast disease. Am J Surg 181 96-100. [Erratum appears in Am J Surg 181:579, 2001 Jun.]
32. JM Kuhn, H Lefebvre, C Duparc, et al. (2002) Cosecretion of estrogen and inhibin B by a feminizing adrenocortical adenoma: impact on gonadotropin secretion. J Clin Endocrinol Metab 87 2367-2375.
33. H Bouraima, B Lireux, H Mittre, et al. (2003) Major hyperestrogenism in a feminizing adrenocortical adenoma despite a moderate overexpression of the aromatase enzyme. Eur J Endocrinol 148 457-461.
34. H Morio, T Terano, K Yamamoto, et al. (1996) Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor. Endocr J 43 387-396.
35. MS Anderson, E Brogi and BM Biller (2001) Occult Leydig cell tumor in a patient with gynecomastia. Endocr Pract 7 267-271.
36. IR Daniels and GT Layer (2003) Testicular tumours presenting as gynaecomastia. Eur J Surg Oncol 29 437-439.
37. JL Gabrilove, GL Nicolis, HA Mitty, et al. (1975) Feminizing interstitial cell tumor of the testis: personal observations and a review of the literature. Cancer 35 1184-1202.
38. WS Hendry, WH Garvie, AK Ah-See, et al. (1984) Ultrasonic detection of occult testicular neoplasms in patients with gynaecomastia. Br J Radiol 57 571-572.
39. JM Kuhn, JA Mahoudeau, L Billaud, et al. (1987) Evaluation of diagnostic criteria for Leydig cell tumours in adult men revealed by gynaecomastia. Clin Endocrinol (Oxf) 26 407-416.
40. RW Whitcomb, RN Schimke, JL Kyner, et al. (1986) Endocrine studies in a male patient with choriocarcinoma and gynecomastia. Am J Med 81 917-920.
41. L Foppiani, D Bernasconi, MP Del, et al. (2005) Leydig cell tumour-induced bilateral gynaecomastia in a young man: endocrine abnormalities. Andrologia 37 36-39.
42. K Sugimoto, S Matsumoto, K Nose, et al. (2006) A malignant Leydig cell tumor of the testis. Int Urol Nephrol 38 291-292.
43. SE Bulun, LS Noble, K Takayama, et al. (1997) Endocrine disorders associated with inappropriately high aromatase expression. J Steroid Biochem Mol Biol 61 133-139.
44. G Schneider, MA Kirschner, R Berkowitz, et al. (1979) Increased estrogen production in obese men. J Clin Endocrinol Metab 48 633-638.
45. AL Southren, J Olivo, GG Gordon, et al. (1974) The conversion of androgens to estrogens in hyperthyroidism. J Clin Endocrinol Metab 38 207-214.
46. WH Cleland, CR Mendelson and ER Simpson (1985) Effects of aging and obesity on aromatase activity of human adipose cells. J Clin Endocrinol Metab 60 174-177.
47. DL Hemsell, CD Edman, JF Marks, et al. (1977) Massive extraglandular aromatization of plasma androstenedione resulting in feminization of a prepubertal boy. J Clin Invest 60 455-464.
48. GD Berkovitz, A Guerami, TR Brown, et al. (1985) Familial gynecomastia with increased extraglandular aromatization of plasma carbon19-steroids. J Clin Invest 75 1763-1769.
49. CA Stratakis, A Vottero, A Brodie, et al. (1998) The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. J Clin Endocrinol Metab 83 1348-1357.
50. G Binder, DI Iliev, A Dufke, et al. (2005) Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred. J Clin Endocrinol Metab 90 484-492.
51. A Tiulpakov, N Kalintchenko, T Semitcheva, et al. (2005) A potential rearrangement between CYP19 and TRPM7 genes on chromosome 15q21.2 as a cause of aromatase excess syndrome. J Clin Endocrinol Metab 90 4184-4190.
52. BZ Paulshock (1980) Tutankhamun and his brothers. Familial gynecomastia in the Eighteenth Dynasty. JAMA 244 160-164.
53. M Wilson, J Mulley, A Gedeon, et al. (1991) New X-linked syndrome of mental retardation, gynecomastia, and obesity is linked to DXS255. Am J Med Genet 40 406-413.
54. M Shozu, S Sebastian, K Takayama, et al. (2003) Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. N Engl J Med 348 1855-1865.
55. M Demura, RM Martin, M Shozu, et al. (2007) Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene. Hum Mol Genet 16 2529-2541.
56. P Coen, H Kulin, T Ballantine, et al. (1991) An aromatase-producing sex-cord tumor resulting in prepubertal gynecomastia. N Engl J Med 324 317-322.
57. MC Hertl, J Wiebel, H Schafer, et al. (1998) Feminizing Sertoli cell tumors associated with Peutz-Jeghers syndrome: an increasingly recognized cause of prepubertal gynecomastia. Plast Reconstr Surg 102 1151-1157.
58. C Kara, AO Kutlu, MS Tosun, et al. (2005) Sertoli cell tumor causing prepubertal gynecomastia in a boy with Peutz-Jeghers syndrome: the outcome of 1-year treatment with the aromatase inhibitor testolactone. Horm Res 63 252-256.
59. H Lefevre, C Bouvattier, N Lahlou, et al. (2006) Prepubertal gynecomastia in Peutz-Jeghers syndrome: incomplete penetrance in a familial case and management with an aromatase inhibitor. Eur J Endocrinol 154 221-227.
60. TM Ulbright, MB Amin and RH Young (2007) Intratubular large cell hyalinizing Sertoli cell neoplasia of the testis: a report of 8 cases of a distinctive lesion of the Peutz-Jeghers syndrome. Am J Surg Pathol 31 827-835.
61. JA Carney and WFJ Young (1992) Primary pigmented nodular adrenocortical disease and its associated conditions. Endocrinologist 2 6-21.
62. B Brown, A Ram, P Clayton, et al. (2007) Conservative management of bilateral Sertoli cell tumors of the testicle in association with the Carney complex: a case report. J Pediatr Surg 42 E13-E15.
63. VR Agarwal, K Takayama, JJ Van Wyk, et al. (1998) Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma. J Clin Endocrinol Metab 83 1797-1800.
64. HP Hsiao, MC Chao, CY Lin, et al. (2005) Feminizing adrenocortical adenoma presenting as heterosexual precocious puberty: report of one case. Acta Pediatr Taiwan 46 97-100. [Erratum appears in Acta Paediatr Taiwan 46:392, 2005.]
65. J Bulard, I Mowszowicz and G Schaison (1987) Increased aromatase activity in pubic skin fibroblasts from patients with isolated gynecomastia. J Clin Endocrinol Metab 64 618-623.
66. H Sasano, M Kimura, S Shizawa, et al. (1996) Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study. J Clin Endocrinol Metab 81 3063-3067.
67. I Czajka-Oraniec, W Zgliczynski, A Kurylowicz, et al. (2008) Association between gynecomastia and aromatase (CYP19) polymorphisms. Eur J Endocrinol 158 721-727.
68. NK Maclaren, CJ Migeon and S Raiti (1975) Gynecomastia with congenital virilizing adrenal hyperplasia (11-beta-hydroxylase deficiency). J Pediatr 86 579-581.
69. RG Kadair, MB Block, FH Katz, et al. (1977) “Masked” 21-hydroxylase deficiency of the adrenal presenting with gynecomastia and bilateral testicular masses. Am J Med 62 278-282.
70. K Frank-Raue, F Raue, S Korth-Schutz, et al. (1989) Clinical features and diagnosis of mild 3-beta-hydroxysteroid dehydrogenase deficiency in men. Dtsch Med Wochenschr 114 331-334.
71. DA Hendrickson and WR Anderson (1970) Diethylstilbestrol therapy gynecomastia. JAMA 213 468.
72. DM Henricks, SL Gray and JL Hoover (1983) Residue levels of endogenous estrogens in beef tissues. J Anim Sci 57 247-255.
73. JM Harrington, GF Stein, RO Rivera, et al. (1978) The occupational hazards of formulating oral contraceptives—a survey of plant employees. Arch Environ Health 33 12-15.
74. SM Rifka, JC Pita, RA Vigersky, et al. (1978) Interaction of digitalis and spironolactone with human sex steroid receptors. J Clin Endocrinol Metab 46 338-344.
75. JS Finkelstein, WF McCully, DT MacLaughlin, et al. (1988) The mortician's mystery. Gynecomastia and reversible hypogonadotropic hypogonadism in an embalmer. N Engl J Med 318 961-965.
76. CV DiRaimondo, AC Roach and CK Meador (1980) Gynecomastia from exposure to vaginal estrogen cream. N Engl J Med 302 1089-1090.
77. EI Felner and PC White (2000) Prepubertal gynecomastia: indirect exposure to estrogen cream. Pediatrics 105 E55.
78. FC Wu, TM Farley, A Peregoudov, et al. (1996) Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Fertil Steril 65 626-636.
79. A Babigian and RT Silverman (2001) Management of gynecomastia due to use of anabolic steroids in bodybuilders. Plast Reconstr Surg 107 240-242.
80. SM Harman, EJ Metter, JD Tobin, et al. (2001) Baltimore Longitudinal Study of Aging: Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86 724-731.
81. S Khosla, LJ Melton III, EJ Atkinson, et al. (1998) Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 83 2266-2274.
82. RJ Santen (1999) The testis: function and dysfunction. SJ Yen,(Eds) Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management Philadelphia: Saunders 632-668.
83. J Aiman, PF Brenner and PC MacDonald (1980) Androgen and estrogen production in elderly men with gynecomastia and testicular atrophy after mumps orchitis. J Clin Endocrinol Metab 50 380-386.
84. FT Aki, MI Tekin and H Ozen (1996) Gynecomastia as a complication of chemotherapy for testicular germ cell tumors. Urology 48 944-946.
85. E Harris, P Mahendra, HH McGarrigle, et al. (2001) Gynaecomastia with hypergonadotrophic hypogonadism and Leydig cell insufficiency in recipients of high-dose chemotherapy or chemo-radiotherapy. Bone Marrow Transplant 28 1141-1144.
86. D Feldman (1986) Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis. Endocr Rev 7 409-420.
87. RT Jensen, MJ Collen, SJ Pandol, et al. (1983) Cimetidine-induced impotence and breast changes in patients with gastric hypersecretory states. N Engl J Med 308 883-887.
88. R Caminos-Torres, L Ma and PJ Snyder (1977) Gynecomastia and semen abnormalities induced by spironolactone in normal men. J Clin Endocrinol Metab 45 255-260.
89. A Abel, A Danek, GD Borasio, et al. (1996) X-chromosomal bulbospinal neuropathy (X-BSN, Kennedy syndrome): an illness with repetitive triplet sequences. Case report, differential diagnosis and molecular genetics aspects. Nervenarzt 67 1011-1019.
90. M Berkhoff, M Sturzenegger, R Spiegel, et al. (1998) X-chromosomal bulbospinal muscular atrophy (Kennedy syndrome). Schweiz Med Wochenschr 128 817-823.
91. A Widmark, SD Fossa, P Lundmo, et al. (2003) Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3. Urology 61 145-151.
92. A Karagiannis, K Tziomalos, A Kakafika, et al. (2007) Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism. Nephrol Dial Transplant 22 293.
93. K Mimidis, V Papadopoulos and G Kartalis (2007) Eplerenone relieves spironolactone-induced painful gynaecomastia in patients with decompensated hepatitis B-related cirrhosis. Scand J Gastroenterol 42 1516-1517.
94. BI Carlin, AD Seftel, MI Resnick, et al. (1997) Finasteride induced gynecomastia. J Urol 158 547.
95. J Geller, G Vazakas, B Fruchtman, et al. (1968) The effect of cyproterone acetate on advanced carcinoma of the prostate. Surg Gynecol Obstet 127 748-758.
96. JW Harmon and MA Aliapoulios (1974) Marijuana-induced gynecomastia: clinical and laboratory experience. Surg Forum 25 423-425.
97. F Boccardo, A Rubagotti, G Conti, et al. (2005) Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer. Cancer Chemother Pharmacol 56 415-420.
98. F Boccardo, A Rubagotti, M Battaglia, et al. (2005) Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. J Clin Oncol 23 808-815.
99. A Dobs and MJ Darkes (2005) Incidence and management of gynecomastia in men treated for prostate cancer. J Urol 174 1737-1742.
100. D Saltzstein, P Sieber, T Morris, et al. (2005) Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole. Prostate Cancer Prostatic Dis 8 75-83.
101. PR Sieber (2007) Treatment of bicalutamide-induced breast events. Expert Rev Anticancer Ther 7 1773-1779.
102. PH Van (2007) Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study [editorial]. Eur Urol 52 115.
103. S Perdona, R Autorino, PS De, et al. (2005) Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial. Lancet Oncol 6 295-300.
104. LG Di and R Autorino (2007) Bicalutamide-induced gynaecomastia: do we have the answer? Eur Urol 52 5-8. [commentary]
105. Y Fradet, B Egerdie, M Andersen, et al. (2007) Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study. Eur Urol 52 106-114.
106. MC Nuttall, JP Harris and GP Dawkins (2007) The role of tamoxifen in reducing bicalutamide-induced gynaecomastia and breast pain. BJU Int 99 243-244.
107. DS Emmanouel, MD Lindheimer and AI Katz (1980) Pathogenesis of endocrine abnormalities in uremia. Endocr Rev 1 28-44.
108. HW Baker, HG Burger, DM de Kretser, et al. (1976) A study of the endocrine manifestations of hepatic cirrhosis. Q J Med 45 145-178.
109. A Biglia, JL Blanco, E Martinez, et al. (2004) Gynecomastia among HIV-infected patients is associated with hypogonadism: a case-control study. Clin Infect Dis 39 1514-1519.
110. J Deonarain, PK Ramdial and B Singh (2008) Bilateral lipomastia in men: a side effect of highly active antiretroviral therapy. Int J Surg Pathol 16 171-175.
111. Gewurz BE, Dezube BJ, Pantanowitz L: HIV and the breast, AIDS Reader 399; 15:392–396, 2005.
112. JA Mira, F Lozano, J Santos, et al. (2004) Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment. Antivir Ther 9 511-517.
113. KL Becker, JL Winnacker, MJ Matthews, et al. (1968) Gynecomastia and hyperthyroidism. An endocrine and histological investigation. J Clin Endocrinol Metab 28 277-285.
114. YK Tan, CR Birch and D Valerio (2001) Bilateral gynaecomastia as the primary complaint in hyperthyroidism. J R Coll Surg Edinb 46 176-177.
115. WB Chan, VT Yeung, CC Chow, et al. (1999) Gynaecomastia as a presenting feature of thyrotoxicosis. Postgrad Med J 75 229-231.
116. RC Allen, AM Wallace and M Royce (2007) Marinol-induced gynecomastia: a case report. Am J Med 120 e1.
117. DF Thompson and JR Carter (2007) Drug-induced gynecomastia. Pharmacotherapyx 13 37-45.
118. Chalazonitis AN, Theodossiades GD, Nomikou E, et al: Bilateral gynecomastia with microcalcifications in an HIV infected hemophilia A patient after HAART. JBR-BTR 89:328-Dec.
119. JF Colin (2008) Gynaecomastia: Drugs and surgical concerns [commentary]. BMJ 336 790.
120. F Desgrandchamps, S Droupy, J Irani, et al. (2006) Effect of dutasteride on the symptoms of benign prostatic hyperplasia, and patient quality of life and discomfort, in clinical practice. BJU Int 98 83-88.
121. V Gardette, D Vezzosi, JC Maiza, et al. (2007) Gynecomastia associated with fenofibrate. Ann Pharmacother 41 508-510.
122. KB Hammons, RF Edwards and WY Rice (2006) Golf-inhibiting gynecomastia associated with atorvastatin therapy. Pharmacotherapy 26 1165-1168.
123. DV Henley, N Lipson, KS Korach, et al. (2007) Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med 356 479-485.
124. G Iaria, L Urbani, G Catalano, et al. (2005) Switch to tacrolimus for cyclosporine-induced gynecomastia in liver transplant recipients. Transplant Proc 37 2632-2633.
125. AV Jelenkovic and LD Ukanovic-Golubovic (2005) Diazepam-associated gynecomastia. Ann Pharmacother 39 201.
126. I Malaga and FX Sanmarti (2006) Two cases of painful gynecomastia and lower extremity pain in association with pregabalin therapy. Epilepsia 47 1576-1579.
127. DN Mendhekar (2005) Clonidine-induced gynecomastia and hyperprolactinemia in a 6-year-old child. J Clin Psychiatry 66 1616-1617.
128. DN Mendhekar and CR Andrade (2005) Unilateral gynecomastia induced by risperidone in a geriatric male patient. Indian J Med Sci 59 361-362.
129. DN Mendhekar and P Srilakshmi (2005) Olanzapine-induced gynecomastia. Aust N Z J Psychiatry 39 736.
130. A Oteri, MA Catania, R Travaglini, et al. (2008) Gynecomastia possibly induced by rosuvastatin. Pharmacotherapy 28 549-551.
131. D Pandhi, R Gupta and A Singal (2006) Gynaecomastia with oligospermia: an unusual complication of low-dose methotrexate for pustular psoriasis. Clin Exp Dermatol 31 138-140.
132. Sahin M, Yilmaz H, Guvener ND: A possible case of gynecomastia with fluoxetine, Ann Pharmacother 39:1369-1Aug.
133. T Satoh, Y Tomikawa, K Takanashi, et al. (2004) Studies on the interactions between drugs and estrogen. III. Inhibitory effects of 29 drugs reported to induce gynecomastia on the glucuronidation of estradiol. Biol Pharm Bull 27 1844-1849.
134. WW Greene and NJ Howard (1953) Relationship of trauma to lesions of the male breast. Am J Surg 85 431.
135. JB Field, RT Solis and WE Dear (1989) Unilateral gynecomastia associated with thoracotomy following resection of carcinoma of the lung. Am J Med Sci 298 402-406.
136. G Mor, W Yue, RJ Santen, et al. (1998) Macrophages, estrogen and the microenvironment of breast cancer. J Steroid Biochem Mol Biol 67 403-411.
137. RJ Heruti, R Dankner, M Berezin, et al. (1997) Gynecomastia following spinal cord disorder. Arch Phys Med Rehabil 78 534-537.
138. PJ Westenend and C Jobse (2002) Evaluation of fine-needle aspiration cytology of breast masses in males. Cancer 96 101-104.
139. H Olsson, A Bladstrom and P Alm (2002) Male gynecomastia and risk for malignant tumours–a cohort study. BMC Cancer 2 26.
140. K Kapila and K Verma (2002) Cytomorphological spectrum in gynaecomastia: a study of 389 cases. Cytopathology 13 300-308.
141. CM Volpe, JD Raffetto, DW Collure, et al. (1999) Unilateral male breast masses: cancer risk and their evaluation and management. Am Surg 65 250-253.
142. AN van Geel, EA van Slooten, M Mavrunac, et al. (1985) A retrospective study of male breast cancer in Holland. Br J Surg 72 724-727.
143. S Zurbiran (1953) Endocrine disturbances in chronic human malnutrition. Vitam Horm 11 93.
144. JE Morley, LA Distiller, J Sagel, et al. (1977) Hormonal changes associated with testicular atrophy and gynaecomastia in patients with leprosy. Clin Endocrinol (Oxf) 6 299-303.
145. E Toma and R Therrien (1998) Gynecomastia during indinavir antiretroviral therapy in HIV infection. AIDS 12 681-682.
146. O Benveniste, A Simon and S Herson (2001) Successful percutaneous dihydrotestosterone treatment of gynecomastia occurring during highly active antiretroviral therapy: four cases and a review of the literature. Clin Infect Dis 33 891-893.
147. KP Hunfeld, R Bassler and H Kronsbein (1997) “Diabetic mastopathy” in the male breast—a special type of gynecomastia. A comparative study of lymphocytic mastitis and gynecomastia. Pathol Res Pract 193 197-205.
148. C Lazala and P Saenger (2002) Pubertal gynecomastia. J Pediatr Endocrinol 15 553-560.
149. ES Sher, CJ Migeon and GD Berkovitz (1998) Evaluation of boys with marked breast development at puberty. Clin Pediatr (Phila) 37 367-371.
150. H Ersoz, ME Onde, H Terekeci, et al. (2002) Causes of gynaecomastia in young adult males and factors associated with idiopathic gynaecomastia. Int J Androl 25 312-316.
151. SL Hines, WW Tan, M Yasrebi, et al. (2007) The role of mammography in male patients with breast symptoms. Mayo Clin Proc 82 297-300.
152. MT McDermott, FD Hofeldt and GS Kidd (1990) Tamoxifen therapy for painful idiopathic gynecomastia. South Med J 83 1283-1285.
153. LN Parker, DR Gray, MK Lai, et al. (1986) Treatment of gynecomastia with tamoxifen: a double-blind crossover study. Metabolism 35 705-708.
154. D Fairlamb and E Boesen (1977) Gynaecomastia associated with gonadotrophin-secreting carcinoma of the lung. Postgrad Med J 53 269-271.
155. DB Jefferys (1979) Painful gynaecomastia treated with tamoxifen. Br Med J 1 1119-1120.
156. T Eversmann, J Moito and WK von (1984) Testosterone and estradiol levels in male gynecomastia. Clinical and endocrine findings during treatment with tamoxifen. Dtsch Med Wochenschr 109 1678-1682.
157. AV Stepanas, RB Burnet, PE Harding, et al. (1977) Clomiphene in the treatment of pubertal-adolescent gynecomastia: a preliminary report. J Pediatr 90 651-653.
158. PV Plourde, HE Kulin and SJ Santner (1983) Clomiphene in the treatment of adolescent gynecomastia. Clinical and endocrine studies. Am J Dis Child 137 1080-1082.
159. D LeRoith, R Sobel and SM Glick (1980) The effect of clomiphene citrate on pubertal gynaecomastia. Acta Endocrinol (Copenh) 95 177-180.
160. M Zachmann, U Eiholzer, M Muritano, et al. (1986) Treatment of pubertal gynaecomastia with testolactone. Acta Endocrinol (Copenh) (Suppl), 218-226.
161. A comparison of danazol and placebo in the treatment of adult idiopathic gynaecomastia: results of a prospective study in 55 patients. Ann R Coll Surg Engl 72 296-298.
162. R Buckle (1979) Danazol therapy in gynaecomastia; recent experience and indications for therapy. Postgrad Med J 55(Suppl-8),
163. AJ Eberle, JT Sparrow and BS Keenan (1986) Treatment of persistent pubertal gynecomastia with dihydrotestosterone heptanoate. J Pediatr 109 144-149.
164. JM Kuhn, R Roca, MH Laudat, et al. (1983) Studies on the treatment of idiopathic gynaecomastia with percutaneous dihydrotestosterone. Clin Endocrinol (Oxf) 19 513-520.
165. TT Alagaratnam (1987) Treating puberty gynecomastia. J R Coll Gen Pract 37 178.
166. R Konig, W Schonberger, P Neumann, et al. (1987) Treatment of marked gynecomastia in puberty with tamoxifen. Klin Padiatr 199 389-391.
167. VR Staiman and FC Lowe (1997) Tamoxifen for flutamide/finasteride-induced gynecomastia. Urology 50 929-933.
168. S Serels and A Melman (1998) Tamoxifen as treatment for gynecomastia and mastodynia resulting from hormonal deprivation. J Urol 159 1309.
169. AC Ting, LW Chow and YF Leung (2000) Comparison of tamoxifen with danazol in the management of idiopathic gynecomastia. Am Surg 66 38-40.
170. W Beck and P Stubbe (1984) Excessive gynecomastia in boys. Effective medical treatment using danazol (Winobanin). Monatsschr Kinderheilkd (Organ), 32-37.
171. W Swoboda and E Bohrn (1981) Steroid treatment of adolescent gynecomastia with danazol (author's transl). Wein Med Wochenschr 131 127-132.
172. O Derman, NO Kanbur and T Kutluk (2003) Tamoxifen treatment for pubertal gynecomastia. Int J Adolesc Med Health 15 359-363.
173. S Hanavadi, D Banerjee, IJ Monypenny, et al. (2006) The role of tamoxifen in the management of gynaecomastia. Breast 15 276-280.
174. HN Khan, R Rampaul and RW Blamey (2004) Management of physiological gynaecomastia with tamoxifen. Breast 13 61-65.
175. SE Lawrence, KA Faught, J Vethamuthu, et al. (2004) Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr 145 71-76.
176. PV Plourde, EO Reiter, HC Jou, et al. (2004) Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 89 4428-4433.
177. N Mauras, K Bishop, D Merinbaum, et al. (2009) Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent onset gynecomastia. J Clin Endocrinol Metab 94 2975-2978.
178. EL Rhoden and A Morgentaler (2004) Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole. Int J Impot Res 16 95-97.
179. FG Riepe, I Baus, S Wiest, et al. (2004) Treatment of pubertal gynecomastia with the specific aromatase inhibitor anastrozole. Horm Res 62 113-118.
180. U Gruntmanis and GD Braunstein (2001) Treatment of gynecomastia. Curr Opin Investig Drugs 2 643-649.
181. LE Hughes (1989) The male breast. RE Mansell, DJT Webster,(Eds) Benign Disorders and Diseases of the Breast Paris: Bailliérè-Tindall 167.
182. GD Braunstein (1999) Aromatase and gynecomastia. Endocr Relat Cancer 6 315-324. [Review] [44 refs]
183. AE Handschin, D Bietry, R Husler, et al. (2008) Surgical management of gynecomastia–a 10-year analysis. World J Surg 32 38-44.
184. F Lista and J Ahmad (2008) Power-assisted liposuction and the pull-through technique for the treatment of gynecomastia. Plast Reconstr Surg 121 740-747.
185. HA Mentz, A Ruiz-Razura, G Newall, et al. (2007) Correction of gynecomastia through a single puncture incision. Aesthetic Plast Surg 31 244-249.
186. M Tashkandi, MM Al-Qattan, JM Hassanain, et al. (1921) The surgical management of high-grade gynecomastia. Ann Plast Surg 53 17-20.
187. EJ Small, MW Frohlich, R Bok, et al. (2000) Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol 18 3595-3603.
188. AP Dicker (2003) The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy. Lancet Oncol 4 30-36. [Review] [54 refs]
189. CJ Tyrrell, H Payne, TL Tammela, et al. (2004) Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia. In J Radiat Oncol Biol Phys 60 476-483.